Information Provided By:
Fly News Breaks for August 5, 2016
ANIP
Aug 5, 2016 | 07:39 EDT
Oppenheimer analyst Rohit Vanjani raised his price target for ANI Pharmaceuticals to $71 from $65 after the company reported "strong" Q2 results and raised guidance. The analyst reiterates an Outperform rating on the shares.
News For ANIP From the Last 2 Days
ANIP
Mar 27, 2024 | 06:51 EDT
ANI Pharmaceuticals announced the launch of Levofloxacin Oral Solution, a generic version of the Reference Listed Drug Levaquin. The current annual U.S. market for Levofloxacin Oral Solution is approximately $7.1M, according to latest estimates from IQVIA/IMS Health, a leading healthcare data and analytics provider.